For the Inventor, By the Inventor

Enter inventor name

Portland, Canada

Clarke Slemon

USPTO Granted Patents = 5 (Patent Applications = 1)

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

Ontario, CA (1996)
Montreal, CA (2004)
Portland, CA (2006 - 2010)

Company Filing History:

Quebepharma Recherche, Inc.

American Diagnostica, Inc.

2 out of 832,812

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2010

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7767646 - Methods of screening for compounds that modulate TAFIa activity, compounds, and methods of using the compounds (2010-08-03),

2. 7316900 - Methylated nucleotide regulation of gene expression (2008-01-08),

3. 7119068 - Methods of screening for compounds that modulate TAFIa activity, compounds, and methods of using the compounds (2006-10-10),

4. 6703504 - Conformationally constrained compounds as dendrimer cores (2004-03-09),

5. 5502195 - Sulfoxide-carboxylate intermediates of omeprazole and lansoprazole (1996-03-26),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…